India Exchange Filings

Sanofi India Q3 2026 Board Meeting Highlights

Sanofi India Ltd reports Q3 2026 net profit of ₹116.7 crore, up 53.6%, and declares ₹75 interim dividend

  • Revenue was ₹491.7 crore, up 3.4% year on year and 12.3% quarter on quarter.
  • PBT margin was 34%, versus 29% in Q3 2025.
  • November 5, 2026 is the dividend record date; the auditor’s limited review reported no material concerns.

Original Filing

This is an automated summary of a public document. Always check the original before relying on it.